This study screened reports of adverse reactions to GLP-1 RAs with the aim of demonstrating that GLP-1 RA-associated psychiatric AEs are highly correlated with GLP-1 RA treatment
No human case reports have documented harm to nursing infants from maternal GLP-1 use
Start your intake Understanding GLP-1 Medications and ADHD Drug Interactions GLP-1 receptor agonists (semaglutide and tirzepatide) work by slowing gastric emptying and signaling fullness in the brain, mechanisms distinct from how ADHD medications function
DISCUSSION The current study has demonstrated that combined incubation of HUVEC with rosuvastatin and L-arginine is likely to be more effective at reducing hyperglycemia-induced oxidative stress than rosuvastatin or L-arginine alone
doi: 10.1111/1753-0407.12891 Summary Keywords diabetic kidney disease, diabetic nephropathy, GLP-1 receptor agonists, liraglutide, semaglutide, dulaglutide Citation Kawanami D and Takashi Y (2020) GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
Many healthcare providers suggest 60100g of protein per day for GLP-1 users, but this varies based on your weight, activity level, and goals
